title: [First surgery followed by vaginal curietherapy in small-volume uterine cervix cancer: an alternative to the association of uterovaginal curietherapy and surgery].
abstract: OBJECTIVE
  Evaluate the results of the treatment of small uterine cervix cancer with the association of surgery and postoperative vaginal brachytherapy, without unfavourable prognostic factors.
  
  
  METHODS
  After radical hysterectomy with lymphadenectomy, 29 women (mean age: 44 years) with carcinoma < 25 mm (26 stage IB1, 3 IIA, mean size: 15 mm) were treated by post-operative prophylactic vaginal brachytherapy using low dose rate. Ovarian transposition was performed at the surgical time in 14 young women (mean age 35 years).
  
  
  RESULTS
  The actuarial specific survival rates at 5 and 10 years were 100% and 90% respectively, with a mean follow-up 75 months. Only one local recurrence was observed. The rate of grade 1 post-operative complication was 7%. The conservation rate of the ovarian function was 85% for young women.
  
  
  CONCLUSIONS
  Treatment of small volume uterine cervix cancer using first surgery and post-operative vaginal brachytherapy is a reliable therapeutic option. The results in terms of specific survival and complications are the same with those after standard association of preoperative uterovaginal brachytherapy and surgery.
authors.affiliation: Service de radiothérapie, institut Bergonié, centre régional de lutte contre le cancer, 229, cours de l'Argonne, 33076 Bordeaux, France.
authors.forename: O
authors.initials: O
authors.lastname: Gallocher
authors.forename: L
authors.initials: L
authors.lastname: Thomas
authors.forename: E
authors.initials: E
authors.lastname: Stöckle
authors.forename: E
authors.initials: E
authors.lastname: Bussières
authors.forename: A
authors.initials: A
authors.lastname: Floquet
authors.forename: A
authors.initials: A
authors.lastname: Avril
authors.forename: J
authors.initials: J
authors.lastname: Pigneux
mesh_terms: D000328:Adult; D000367:Age Factors; D001918:Brachytherapy; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007044:Hysterectomy; D008197:Lymph Node Excision; D008875:Middle Aged; D010053:Ovary / Q000502:physiology; D011182:Postoperative Care; D011879:Radiotherapy Dosage; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*